Chapter 10: Drug Therapy for Dyslipidemia Flashcards

1
Q

Accumulation of abdominal body fat, resulting in an increased waist circumference.

A

Central adiposity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Component of the cell membrane that is produced and processed in the liver, a fat essential for the formation of steroid hormones that are produced in cells and taken in by dietary sources.

A

Cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Abnormal lipid levels in the blood; associated with atherosclerosis and its many pathophysiologic effects. (Myocardial ischemia and infarction, stroke, peripheral arterial occlusive disease.)

A

Dyslipidemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Specific proteins in plasma that transport blood lipids; contain cholesterol, phospholipid, and triglyceride bound to protein. They vary in density and amounts of lipids and proteins.

A

Lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A cluster of several cardiovascular risk factors linked with obesity; increased waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol. elevated blood pressure, and elevated fasting glucose.

A

Metabolic syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Total serum cholesterol (mg/dL) in Adults:

A

Desirable = <200 Borderline = 200–239 Undesirable = 240 or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LDL cholesterol (mg/dL) in Adults:

A

Desirable = <130 Borderline = 130–159 Undesirable = 160 or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HDL cholesterol (mg/dL) in adults:

A

Desirable = 40 or above* Undesirable = <40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Triglycerides (mg/dL) in Adults:

A

Triglycerides (mg/dL) Desirable = <150 Borderline = 150–199 Undesirable = 200 or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Total serum cholesterol (mg/dL) in children:

A

Desirable = <170 Borderline = 170–199 Undesirable = 200 or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

LDL cholesterol (mg/dL) in children:

A

Desirable = 110–129 Undesirable = >130 or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HDL cholesterol (mg/dL) in children

A

Desirable level = >45 Borderline = 35–45 Undesirable = <35

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Triglycerides (mg/dL) in children:

A

Desirable = <125 Undesirable = >125 or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Cholestyramine?

A

Cholestyramine (Prevalite, Questran), the prototype bile acid sequestrant, has the ability to reduce LDL cholesterol. It has little or no effect on HDL cholesterol and either no effect or an increased effect on triglyceride levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Route and dosage ranges of Cholestyramine: Prevalite, Questran

A

PO tablets, 4 g once or twice daily initially, gradually increased at monthly intervals to 8–16 g daily in 2 divided doses. Maximum daily dose, 24 g PO powder, 4 g 1–6 times daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Route and dosage range of Fenofibrate (Antara, TriCor, Lofibra, Trilipix)

A

Fenofibrate (micronized) PO 67 mg three times daily with meals increased if necessary to a maximum dose of 268 mg (4 capsules) daily

17
Q

Ezetimibe (Zetia) Route and dosage range:

A

PO 10 mg once daily.

18
Q

Drugs that increase the effects of Atorvastatin:

A

Magnesium and aluminum containing antacids: Interfere with absorption.
Amiodarone and colchine: Decrease metabolism.
Azole Antifungals: Increase the risk of myopathy recommended that statin therapy be interrupted.
Cyclosporine, CYPA34 inhibitors, diltiazem, fibric acid derivatives, niacin, verapamil: Increase the risk of severe myopathy or rhabdomyolysis.
Erythromycin, macrolide antibiotics, nefazodone, and protease inhibitors Decrease elimination

19
Q

Drugs That Decrease the Effects of Atorvastatin

A

Cholestyramine Decreases rate of bioavailability; administer atorvastatin at least 4 hours after this bile acid sequestrant. Colestipol Decreases plasma levels

20
Q

Drugs That Increase the Effects of Fenofibrate

A

Statins Increase the risk of severe myopathy or rhabdomyolysis Cyclosporine Mechanism for increase is unknown.

21
Q

Drugs That Decrease the Effects of Fenofibrate

A

Bile acid sequestrant drugs Decrease absorption; to avoid, take fenofibrate about 1 hour before or 4 to 6 hours after the bile acid sequestrant.

22
Q

Drugs That Increase the Effects of Ezetimibe

A

Cyclosporine Increases blood levels

23
Q

Drugs That Decrease the Effects of Ezetimibe

A

Bile acid sequestrant drugs Mechanism for decrease is unknown.

24
Q

What drugs can Cholestyramine decrease the absorption of?

A

Cholestyramine may decrease absorption of many oral medications (e.g., digoxin, folic acid, glipizide, propranolol, tetracyclines, thiazide diuretics, thyroid hormones, fat-soluble vitamins, and warfarin).

25
Q

Route and dosage range of holestyramine (Prevalite, Questran;

A

PO tablets, 4 g once or twice daily initially, gradually increased at monthly intervals to 8–16 g daily in 2 divided doses. Maximum daily dose, 24 g PO powder, 4 g 1–6 times daily

26
Q

Route and dosage ranges of Alirocumab (Praluent)

A

Sub-Q: 75–150 mg every 2 wk

27
Q

Route and dosage ranges of Niacin (immediate release) (Niacor, Niaspan

A

PO 1–6 g daily, in 3 or 4 divided doses, with or just after meals